Press "Enter" to skip to content

New patent for Nextwave Pharms drug QUILLICHEW ER

1
Copyright © DrugPatentWatch. Originally published at New patent for Nextwave Pharms drug QUILLICHEW ER

Annual Drug Patent Expirations for QUILLICHEW+ER
Annual Drug Patent Expirations for QUILLICHEW+ER

Quillichew Er is a drug marketed by Nextwave Pharms and is included in one NDA. It is available from two suppliers. There are six patents protecting this drug.

QUILLICHEW ER drug price trends.

Drug patent litigation for QUILLICHEW ER.

This drug has thirty-four patent family members in fourteen countries.

The generic ingredient in QUILLICHEW ER is methylphenidate hydrochloride. Two suppliers are listed for this compound. Additional details are available on the methylphenidate hydrochloride profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Nextwave Pharms drug QUILLICHEW ER
Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

DrugPatentWatch - Make Better Decisions